http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8044038-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_411b62e38c435f70581003b45e59ed02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D281-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-16
filingDate 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c72a55041c7907a90f8801276e409ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b3c47e22d368c1ba560b214bc5bba96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03699cb8b639946d9217999c5128fa72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a07e07410e3aded246222adaf61aa3
publicationDate 2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8044038-B2
titleOfInvention Crystallization process of quetiapine hemifumarate
abstract The present invention relates to a process for preparing crystalline quetiapine hemifumarate, which comprises crystallizing or re-crystallizing quetiapine hemifumarate from a mixture of water and a water soluble alcohol.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993486-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10940155-B2
priorityDate 2005-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6372734-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0155125-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004076431-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240228-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03080065-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322762144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129409886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457669956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123677602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226720188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127480562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127963666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399230

Total number of triples: 46.